Supernus Pharmaceuticals | SUPN - Валовая прибыль





Валовая прибыль Изменить Дата
Abbott USD 6.65B 787M 2026-06
ANI Pharmaceuticals USD 143.88M 19.7M 2026-03
Aurora Cannabis CAD 29.79M 16.83M 2026-03
Bristol-Myers Squibb USD 9.26B 1.19B 2026-06
Canopy Growth CAD 8.26M 13.2M 2026-03
Cara Therapeutics USD 2.57M 1.11M 2025-03
Corcept Therapeutics USD 252.09M 90.07M 2026-06
Eisai JPY 183.24B 29.83B 2026-06
Eli Lilly USD 16.22B 301.7M 2026-03
Novo Nordisk DKK 64.01B 1.19B 2025-06
Pacira USD 133.91M 7.27M 2026-06
Perrigo USD 313.9M 11.6M 2026-06
Pfizer USD -248M 11.29B 2026-06
Supernus Pharmaceuticals USD 160.06M 30.7M 2026-06
United Therapeutics USD 683.8M 35.7M 2026-06
Xeris Pharmaceuticals USD 72.55M 404K 2026-03